What are the recent trends in market size and growth for the intermittent pneumatic compression (ipc) devices market?
The intermittent pneumatic compression (IPC) devices market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to improved disease understanding, increased awareness and diagnosis, changing healthcare policies, collaborations in clinical trials, supportive patient advocacy, physician education programs.
The intermittent pneumatic compression (IPC) devices market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing patient pool, increased focus on patient quality of life, expanding research collaborations, global health initiatives, increasing healthcare access. Major trends in the forecast period include emergence of targeted therapies, development of oral and injectable medications, investigation of immune modulation strategies, introduction of disease-modifying agents, focus on personalized medicine approaches.
Get Your Free Sample of The Global Intermittent Pneumatic Compression (IPC) Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13460&type=smp
What have been the primary factors driving the intermittent pneumatic compression (ipc) devices market’s growth?
The growing number of patients with spinal cord injuries is expected to propel the growth of the intermittent pneumatic compression (IPC) devices market going forward. A spinal cord injury is a damage to the spinal cord that results in loss of function, typically causing varying degrees of paralysis and sensory impairment below the level of the injury. Intermittent pneumatic compression (IPC) devices are employed in spinal cord injury management to prevent deep vein thrombosis (DVT) by promoting blood circulation through sequential compression of the lower limbs. For instance, in 2023, according to the National Spinal Cord Injury Statistical Center, a US-based government organization, roughly 18,000 new cases of spinal cord injuries are reported annually in the United States. The annual incidence rate of spinal cord injuries is approximately 54 cases per 1 million people. Therefore, the growing number of patients with spinal cord injuries is driving the growth of the intermittent pneumatic compression (IPC) devices market.
What are the key segments within the intermittent pneumatic compression (ipc) devices market?
The intermittent pneumatic compression (IPC) devices market covered in this report is segmented –
1) By Type: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)
2) By Distribution Channel: Clinics, Pharmacies, Online Channels, Other Offline Channels
3) By Application: Home Use, Hospital
Subsegments:
1) By Deep Vein Thrombosis (DVT): Portable DVT Compression Devices, Non-Portable (Stationary) DVT Compression Devices, Sequential Compression Devices for DVT
2) By Pulmonary Embolism (PE): Portable PE Compression Devices, Non-Portable (Stationary) PE Compression Devices, Sequential Compression Devices for PE
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/intermittent-pneumatic-compression-ipc-devices-global-market-report
Which key players are shaping the intermittent pneumatic compression (ipc) devices market?
Major companies operating in the intermittent pneumatic compression (ipc) devices market report are Cardinal Health Inc., 3M Company, Medtronic PLC, Stryker Corporation, Tyco International PLC, Medline Industries LP, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Getinge AB, Enovis Corporation, Arjo AB, Tactile Systems Technology Inc., ThermoTek Inc., Encompass Group LLC, Hyperice Inc., Breg Inc., Currie Medical Specialties Inc., ManaMed Inc., Bio Compression Systems Inc., Direct Healthcare Group Ltd., Devon Medical Inc., Mego Afek A.C. Ltd., BSN medical GmbH, Compression Therapy UK Limited, Air Relax Inc., Innova Medical Group Inc.
How will emerging trends drive the intermittent pneumatic compression (ipc) devices market throughout the forecast period?
Major companies operating in the intermittent pneumatic compression (IPC) devices market are increasing their focus on developing innovative devices, such as wearable devices, to gain a competitive edge in the market. Wearable intermittent pneumatic compression devices improve circulation and prevent deep vein thrombosis (DVT) in individuals, especially during prolonged periods of immobility. For instance, in March 2022, Fist Assist Devices LLC, a US-based medical device company, launched Fist Assist Model FA-1, a wearable, patent-protected, intermittent pneumatic compression device worn on the arm to promote vein dilation. It is the world’s first wearable device for presurgical vein dilation that promotes arteriovenous fistula (AVF). The device is automated, which means that it can be used without the need for manual adjustments. It makes it easy to use and reduces the risk of user error. It promotes vein dilation by applying pressure to the arm cyclically, which helps improve blood flow and vein dilation.
How do regional factors impact the intermittent pneumatic compression (ipc) devices market, and which region is the largest contributor?
North America was the largest region in the intermittent pneumatic compression (IPC) devices market in 2024. The regions covered in the intermittent pneumatic compression (ipc) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Intermittent Pneumatic Compression (IPC) Devices Market Report 2025 Offer?
The intermittent pneumatic compression (ipc) devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Intermittent pneumatic compression (IPC) devices are inflatable sleeves designed to prevent blood clots by applying external pressure to the legs using compressed air and a pump. They consist of cuffs that periodically inflate and deflate, promoting blood flow by compressing and releasing the affected area. It is commonly used to improve limb circulation, prevent deep vein thrombosis (DVT), and manage conditions such as lymphedema.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13460
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
